Considering the diversity of receptor types (TrkB full-length, truncated isoform, and p75NTR), neurotrophin forms (precursor or mature form), and their diverse distribution in the brain regions, further cellular/molecular information regarding neurotrophin biology in the target region is required to stimulate specific signaling for the treatment of brain diseases. This evidence concerns the gene NTRK2 and brain disorder.